These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37552454)

  • 1. Usefulness of the aldehyde breath test for predicting metachronous recurrence in patients with esophageal squamous cell carcinoma and hypopharyngeal squamous cell carcinoma.
    Sasaki F; Mawatari S; Oda K; Yano H; Maeda H; Tanaka A; Arima S; Kumagai K; Tanoue S; Hashimoto S; Kanmura S; Ido A
    Esophagus; 2023 Oct; 20(4):749-756. PubMed ID: 37552454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetaldehyde breath test as a cancer risk marker in patients with esophageal and hypopharyngeal squamous cell carcinoma.
    Sasaki F; Kanmura S; Oda K; Maeda H; Kabayama M; Iwaya H; Komaki Y; Arima S; Tanoue S; Hashimoto S; Fujita H; Ido A
    PLoS One; 2021; 16(5):e0251457. PubMed ID: 34010294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation.
    Ogasawara N; Kikuchi D; Inoshita N; Nakayama A; Kohno K; Ochiai Y; Hayasaka J; Suzuki Y; Dan N; Okamura T; Mitsunaga Y; Tanaka M; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S; Iizuka T
    Esophagus; 2021 Oct; 18(4):806-816. PubMed ID: 33974189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive risk evaluation for metachronous carcinogenesis after endoscopic submucosal dissection of superficial pharyngeal squamous cell carcinoma.
    Ogasawara N; Kikuchi D; Tanaka M; Ochiai Y; Okamura T; Hayasaka J; Suzuki Y; Mitsunaga Y; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S
    Esophagus; 2022 Jul; 19(3):460-468. PubMed ID: 35099639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
    Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Expression of NRF2 Target Genes after Alcohol Exposure in the Background Esophageal Mucosa of Patients with Esophageal Squamous Cell Carcinoma.
    Toda S; Hatta W; Asanuma K; Asano N; Ono Y; Abe H; Ogata Y; Saito M; Kanno T; Jin X; Uno K; Koike T; Imatani A; Hamada S; Nakamura T; Nakaya N; Masamune A
    Tohoku J Exp Med; 2022 Oct; 258(3):195-206. PubMed ID: 36070895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Kim GH; Min YW; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    PLoS One; 2020; 15(9):e0238113. PubMed ID: 32886924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
    Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
    Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar survival after endoscopic submucosal dissection and esophagectomy in early esophageal cancer and synchronous or metachronous head and neck cancer.
    Ke RT; Hsiao YH; Tai WC; Li SH; Yao CC; Chuang KH; Lai HH; Chen Y; Chen LC; Lu HI; Chen YH; Lo CM
    J Cardiothorac Surg; 2024 Feb; 19(1):52. PubMed ID: 38311758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan.
    Hsu MH; Wang WL; Chen TH; Tai CM; Wang HP; Lee CT
    BMC Gastroenterol; 2021 Aug; 21(1):308. PubMed ID: 34344303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage endoscopic resection for cT1N0M0 local recurrence after chemoradiotherapy for esophageal squamous cell carcinoma: endoscopic submucosal dissection versus endoscopic mucosal resection.
    Nakajo K; Yoda Y; Yamashita H; Takashima K; Murano T; Kadota T; Shinmura K; Ikematsu H; Akimoto T; Yano T
    Jpn J Clin Oncol; 2022 Sep; 52(9):982-991. PubMed ID: 35675653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: temperance reduces the risk.
    Abiko S; Shimizu Y; Miyamoto S; Ishikawa M; Matsuda K; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Ono K; Sakamoto N
    J Gastroenterol; 2018 Oct; 53(10):1120-1130. PubMed ID: 29423536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: yield rate, completion rate, and safety.
    Wang CH; Lee YC; Wang CP; Chen CC; Ko JY; Han ML; Chen TC; Lou PJ; Yang TL; Hsiao TY; Wu MS; Wang HP; Tseng PH
    Dig Endosc; 2014 Jan; 26(1):24-31. PubMed ID: 23551305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in elderly patients: a single-center retrospective cohort study.
    Ishido K; Tanabe S; Katada C; Kubota Y; Furue Y; Wada T; Watanabe A; Koizumi W
    Jpn J Clin Oncol; 2021 May; 51(6):895-904. PubMed ID: 33738500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
    Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
    Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of planned surveillance for detecting second primary head and neck cancers after endoscopic resection of esophageal squamous cell carcinoma.
    Shinozaki T; Katada C; Shiga K; Asakage T; Yokoyama T; Yano T; Oda I; Shimizu Y; Takemura K; Ishikawa H; Yokoyama A; Muto M
    Jpn J Clin Oncol; 2020 Sep; 50(10):1162-1167. PubMed ID: 32533160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma according to genetic polymorphisms related to alcohol and nicotine metabolism.
    Katada C; Yokoyama T; Mure K; Doyama H; Nakanishi H; Shimizu Y; Yamamoto K; Furue Y; Tamaoki M; Koike T; Kawahara Y; Kiyokawa H; Konno M; Yokoyama A; Ohashi S; Ishikawa H; Yokoyama A; Muto M
    Jpn J Clin Oncol; 2023 Aug; 53(9):774-780. PubMed ID: 37370215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.